Sangamo Therapeutics, Inc.
METHODS AND COMPOSITIONS FOR MODIFICATION OF A CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) GENE
Last updated:
Abstract:
Nucleases and methods of using these nucleases for alteration of a CFTR gene and generation of cells and animal models.
Status:
Application
Type:
Utility
Filling date:
2 May 2018
Issue date:
12 Mar 2020